Aura Biosciences (AURA) Earnings Date & Reports

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AURA is expected to report earnings to fall 23.44% to -36 cents per share on November 05

Aura Biosciences AURA Stock Earnings Reports

Q3'26

Est.

$-0.37

Q2'26

Missed

by $0.07

Q1'26

Missed

by $0.06

Q4'25

Beat

by $0.09

Q3'25

Beat

by $0.06

The last earnings report on August 11 showed earnings per share of -47 cents, missing the estimate of -40 cents. With 267.84K shares outstanding, the current market capitalization sits at 767.42M.

View a ticker or compare two or three

AURA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days